Literature DB >> 31584659

Epithelial cell infection by Epstein-Barr virus.

Jia Chen1, Richard Longnecker1.   

Abstract

Epstein-Barr Virus (EBV) is etiologically associated with multiple human malignancies including Burkitt lymphoma and Hodgkin disease as well as nasopharyngeal and gastric carcinoma. Entry of EBV into target cells is essential for virus to cause disease and is mediated by multiple viral envelope glycoproteins and cell surface associated receptors. The target cells of EBV include B cells and epithelial cells. The nature and mechanism of EBV entry into these cell types are different, requiring different glycoprotein complexes to bind to specific receptors on the target cells. Compared to the B cell entry mechanism, the overall mechanism of EBV entry into epithelial cells is less well known. Numerous receptors have been implicated in this process and may also be involved in additional processes of EBV entry, transport, and replication. This review summarizes EBV glycoproteins, host receptors, signal molecules and transport machinery that are being used in the epithelial cell entry process and also provides a broad view for related herpesvirus entry mechanisms. © FEMS 2019.

Entities:  

Keywords:  Epstein–Barr virus; epithelial cells; gamma-herpesviruses

Mesh:

Substances:

Year:  2019        PMID: 31584659      PMCID: PMC7317989          DOI: 10.1093/femsre/fuz023

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  99 in total

1.  Focal adhesion kinase plays a pivotal role in herpes simplex virus entry.

Authors:  Natalia Cheshenko; Wen Liu; Lisa M Satlin; Betsy C Herold
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

2.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

Review 3.  How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns.

Authors:  Ian C Zachary
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

4.  Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.

Authors:  Carrie B Coleman; Eric M Wohlford; Nicholas A Smith; Christine A King; Julie A Ritchie; Paul C Baresel; Hiroshi Kimura; Rosemary Rochford
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

5.  HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Authors:  Sophie Lambert; Manuella Bouttier; Roger Vassy; Michel Seigneuret; Cari Petrow-Sadowski; Sébastien Janvier; Nikolaus Heveker; Francis W Ruscetti; Gérard Perret; Kathryn S Jones; Claudine Pique
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

6.  Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome.

Authors:  Zhe Shao; Wen-Feng Zhang; Xin-Ming Chen; Zheng-Jun Shang
Journal:  Oral Oncol       Date:  2008-05-15       Impact factor: 5.337

7.  Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor.

Authors:  H Jacques Garrigues; Yelena E Rubinchikova; C Michael Dipersio; Timothy M Rose
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

8.  Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis.

Authors:  Yangyang She; Xiaolin Nong; Min Zhang; Menglin Wang
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

9.  Modulation of Epstein-Barr virus glycoprotein B (gB) fusion activity by the gB cytoplasmic tail domain.

Authors:  Nicholas J Garcia; Jia Chen; Richard Longnecker
Journal:  MBio       Date:  2013-01-22       Impact factor: 7.867

10.  EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination.

Authors:  Dipanjan Dutta; Sayan Chakraborty; Chirosree Bandyopadhyay; Mohanan Valiya Veettil; Mairaj Ahmed Ansari; Vivek Vikram Singh; Bala Chandran
Journal:  PLoS Pathog       Date:  2013-07-18       Impact factor: 6.823

View more
  19 in total

Review 1.  Epstein-Barr virus: Biology and clinical disease.

Authors:  Blossom Damania; Shannon C Kenney; Nancy Raab-Traub
Journal:  Cell       Date:  2022-09-15       Impact factor: 66.850

2.  The Potential for EBV Vaccines to Prevent Multiple Sclerosis.

Authors:  Peter A Maple; Alberto Ascherio; Jeffrey I Cohen; Gary Cutter; Gavin Giovannoni; Claire Shannon-Lowe; Radu Tanasescu; Bruno Gran
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

3.  Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles.

Authors:  Nian Ma; Juan Lu; Yonggang Pei; Erle S Robertson
Journal:  Cell Death Dis       Date:  2022-10-22       Impact factor: 9.685

4.  Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients.

Authors:  Fang Lu; Kayla A Martin; Samantha S Soldan; Andrew V Kossenkov; Priyankara Wickramasinghe; Olga Vladimirova; Alessandra De Leo; Cindy Lin; Yulia Nefedova; Paul M Lieberman
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

5.  Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes.

Authors:  Samantha S Soldan; Chenhe Su; R Jason Lamontagne; Nicholas Grams; Fang Lu; Yue Zhang; James D Gesualdi; Drew M Frase; Lois E Tolvinski; Kayla Martin; Troy E Messick; Jonathan T Fingerut; Ekaterina Koltsova; Andrew Kossenkov; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2021-06-09       Impact factor: 6.823

Review 6.  Pathogenesis and Immune Response Caused by Vector-Borne and Other Viral Infections in a Tupaia Model.

Authors:  Mohammad Enamul Hoque Kayesh; Md Abul Hashem; Bouchra Kitab; Kyoko Tsukiyama-Kohara
Journal:  Microorganisms       Date:  2019-12-12

Review 7.  Epstein-Barr Virus and Systemic Autoimmune Diseases.

Authors:  Gunnar Houen; Nicole Hartwig Trier
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 8.  Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies.

Authors:  Rancés Blanco; Francisco Aguayo
Journal:  Biology (Basel)       Date:  2020-12-11

Review 9.  Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis.

Authors:  Manikandan Palrasu; Elena Zaika; Wael El-Rifai; Jianwen Que; Alexander I Zaika
Journal:  Cancers (Basel)       Date:  2021-04-14       Impact factor: 6.575

Review 10.  Clinical Manifestations and Epigenetic Regulation of Oral Herpesvirus Infections.

Authors:  Natalie Atyeo; Michelle D Rodriguez; Bernadett Papp; Zsolt Toth
Journal:  Viruses       Date:  2021-04-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.